No profile data available.
OraSure Technologies, Inc. (OSUR) is a healthcare company in the chemical laboratory testing equipment industry, based in Bethlehem, United States, with about 500 full-time employees.
It reported revenue of $185.83 million for fiscal year 2024, down 54.2% from fiscal year 2023, and net income of -$19.50 million. In Q3 2025 (the quarter ended September 30, 2025) revenue was $27.09 million, down 32.1% from a year before. United States was its largest region in fiscal year 2025, with 68% of revenue. Its market capitalization was $268.98 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
, together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. D. saliva alcohol test.
OraSure Technologies reported $185.83 million in revenue for fiscal year 2024, down 54.2% from $405.47 million in fiscal year 2023. In Q3 2025 revenue was $27.09 million.
United States: 68% of revenue by region in fiscal year 2025, followed by Africa (21%).
$268.98 million as of October 9, 2026.
Listed companies of a similar size in the same industry (chemical laboratory testing equipment) include DexCom, Inc. (DXCM), Senseonics Holdings, Inc. (SENS), Anbio Biotechnology (NNNN), DarioHealth Corp. (DRIO).